|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,866 GBX | -.--% |
|
-.--% | +0.21% |
| 10/06 | Dechra Pharmaceuticals Limited Appoints Jonathan David Lang as Director | CI |
| 15/04 | Dechra Pharmaceuticals Limited acquired 33.34% stake in STEM Animal Health Inc. | CI |
(Reuters) - Veterinary firm Dechra Pharmaceuticals Plc said it would buy the Netherlands-based AST Farma and Europe-focused Le Vet for 340 million euros (296.79 million pounds) in a cash and share deal.
The debt-free, cash-free deal will see Dechra paying about 75 percent in cash and 25 percent in new Dechra shares, and subject to a two year lock-in, Dechra said in a statement.
(Reporting By Justin George Varghese in Bengaluru; Editing by Gopakumar Warrier)
DECHRA PHARMACEUTICALS 
